Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2012
10/10/2012EP2507257A1 Mybl2 peptides and vaccines containing the same
10/10/2012EP2507256A1 Imp-3 oligopeptides and vaccines including the same
10/10/2012EP2507255A1 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
10/10/2012CN1973053B Novel anti-IL 13 antibodies and uses thereof
10/10/2012CN1953989B Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
10/10/2012CN1622821B Method of stimulating growth and resistance to diseases of aquatic organisms
10/10/2012CN102725639A Positively charged species as binding reagents in the separation of protein aggregates from monomers
10/10/2012CN102725311A Methods of treating inflammation
10/10/2012CN102725305A Melanocortin-1 receptor-specific cyclic peptides
10/10/2012CN102718842A Process for extracting colistin sulfate through precipitation method
10/10/2012CN102718841A Method for purification of peptide biological material
10/10/2012CN102718840A Human MMP-14 antigen, corresponding monoclonal antibody and application thereof
10/10/2012CN102718839A Method for separating and purifying daptomycin
10/10/2012CN102718838A Short peptide and immunosuppressant containing the same and application
10/10/2012CN102718837A Short peptide, immunosuppressant containing short peptide, and applications
10/10/2012CN102718836A Short peptide, immune inhibitor containing the same and application thereof
10/10/2012CN102718835A Short peptide and immunosuppressant containing the same and application
10/10/2012CN102086226B Method for preparing cyclosporine A
10/10/2012CN101948513B L27e family protein antigen epitope, antibody and application thereof
10/10/2012CN101613395B Improved gene construction method and property testing of fast-acting insulin precursor
10/10/2012CN101287988B Methods and compositions for diagnosis and treatment of influenza
10/10/2012CN101287484B Binding agents which inhibit myostatin
10/09/2012US8283441 Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
10/09/2012US8283311 Peptide-containing food intake regulator
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2382035C Synthetic compounds having two epitopes in immunoassay
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/09/2012CA2164698C Synthetic peptide inhibitors of hiv transmission
10/04/2012WO2012135666A1 Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
10/04/2012WO2012135385A1 Methods and compositions related to inhibition of viral entry
10/04/2012WO2012131504A1 Pcsk9 vaccine
10/04/2012WO2012130999A1 Peptides isolated and purified from fruit bat testicles
10/04/2012WO2012130775A1 Pgc-1alpha-modulating peptides
10/04/2012WO2012130771A1 Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
10/04/2012WO2012097220A3 Novel vesicles and nanostructures from recombinant proteins
10/04/2012US20120253010 Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling
10/04/2012US20120253008 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
10/04/2012US20120252734 Inhibitors of antigen presentation by mhc class ii molecules
10/04/2012US20120252731 Co-Administration of An Agent Linked to an Internalization Peptide With an Anti-Inflammatory
10/04/2012US20120252730 Platelet aggregation inhibitors
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251502 Human Ebola Virus Species and Compositions and Methods Thereof
10/04/2012US20120251453 Methods and Compositions Related to Annexin 1-Binding Compounds
10/04/2012US20120251445 Peptides whose uptake by cells is controllable
10/04/2012CA2830375A1 Methods and compositions for targeting adipose cells in mammals
10/03/2012EP2504352A1 Melanocortin-1 receptor-specific cyclic peptides
10/03/2012EP2504351A1 Melanocortin-1 receptor-specific linear peptides
10/03/2012CN1894281B Treatment of viral infections
10/03/2012CN102712677A Lipopeptide compositions and related methods
10/03/2012CN102712676A Template-fixed peptidomimetics with CCR10 antagonistic activty
10/03/2012CN102712675A Peptidomimetic macrocycles
10/03/2012CN102712674A Melanocortin-1 receptor-specific linear peptides
10/03/2012CN102711789A Therapeutic agents for reducing parathyroid hormone levels
10/03/2012CN102702353A Anti-glypican 3 antibody
10/03/2012CN102702330A Intermedin analogue prepared by bonding ring core sequence with biotin or cell-penetrating peptides
10/03/2012CN102702329A Synthesis of template-fixed Beta-hairpin loop mimics
10/03/2012CN102702328A Method for extracting asterin from aster
10/03/2012CN102702327A Solid-liquid phase synthesis method for alarelin acetate
10/03/2012CN102702326A Epitope of systemic lupus erythematosus and application thereof
10/03/2012CN102702325A Preparation method of anticoagulant polypeptide
10/03/2012CN102702324A Application of human procalcitonin B cell epitope peptide fragment and monoclonal antibody thereof
10/03/2012CN102702323A Application of procalcitonin B cell epitope peptide fragment and monoclonal antibody thereof
10/03/2012CN102702322A H1 subtype specific conserved epitope, antibody and application thereof
10/03/2012CN102702321A Method for purifying eptifibatide acetate
10/03/2012CN102702320A Method for preparing eptifibatide
10/03/2012CN102702319A HLA-A*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
10/03/2012CN102702318A YIGSKYIGSK with target antithrombotic activity, and preparation and application thereof
10/03/2012CN102702317A RGDSYIGSR with target antithrombotic activity, preparation and application thereof
10/03/2012CN102702316A RGDFYIGSK with targeting antithrombotic activity, preparation and applications thereof
10/03/2012CN102702315A RGDSYIGSK with targeting antithrombotic activity, preparation and applications thereof
10/03/2012CN102702314A RGDF-YIGSR with targeted anti-thrombotic activity, preparation and application thereof
10/03/2012CN102702313A RGDV-YIGSR with targeted anti-thrombotic activity, preparation and application thereof
10/03/2012CN102702312A RGDVYIGSK with targeting antithrombotic activity, preparation and applications thereof
10/03/2012CN102702310A Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines
10/03/2012CN101857630B Fluorouracil derivative containing tyrosine-isoleucine-glycine-serine-arginine polypeptide
10/03/2012CN101798338B Application of anti-opioid peptide antagonist peptide
10/03/2012CN101668778B Preparation of low bleeding anticoagulant fusion protein and its use
10/03/2012CN101538314B Method for purifying Eptifibatide
10/02/2012US8278280 Antagonists of the bradykinin B1 receptor
10/02/2012US8278264 Compositions and methods for enhancing drug delivery across and into ocular tissues
10/02/2012US8277792 Peptides for active anti-cytokine immunization
10/02/2012CA2492883C Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/2012
09/30/2012CA2772767A1 Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling
09/27/2012WO2012129457A2 Diagnostic and treatment methods using a ligand library
09/27/2012WO2012129423A2 Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
09/27/2012WO2012127739A1 Novel carrier molecule and method both for delivering rna into cytoplasm using near-infrared light
09/27/2012WO2012126441A2 Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
09/27/2012WO2012126172A1 Peptides inhibiting adhesion of aspergillus fumigatus to cornea
09/27/2012WO2012126118A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012WO2012126047A1 Agent and method for treating pain and reducing inflammation
09/27/2012US20120245099 Apoptosis inducer
09/27/2012US20120245097 Use of pedf-derived polypeptides for promoting stem cells proliferation and wound healing
09/27/2012US20120245094 Compounds, compositions and use
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120245086 WNT10-Derived Peptide and Use Thereof
09/27/2012US20120244615 Isolated a-type fhf n-terminal domain peptides and methods of use
09/27/2012US20120244174 Treatment of tauopathies
09/27/2012US20120244136 Cardiac-Specific Protein Targeting Domain
09/27/2012US20120244123 Therapeutic agents
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 423